Selkirk Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-102,000
Closed -$1.48M 21
2016
Q4
$1.48M Hold
102,000
0.94% 18
2016
Q3
$2.5M Hold
102,000
1.54% 16
2016
Q2
$2.05M Buy
102,000
+47,000
+85% +$1.33M 1.24% 19
2016
Q1
$1.45M Sell
55,000
-19,000
-26% -$1.41M 0.9% 19
2015
Q4
$7.52M Buy
74,000
+24,216
+49% +$2.72M 4.43% 10
2015
Q3
$8.88M Sell
49,784
-5,700
-10% -$1.33M 5.51% 6
2015
Q2
$12.3M Hold
55,484
6.76% 5
2015
Q1
$11M Hold
55,484
6.12% 5
2014
Q4
$7.94M Hold
55,484
4.74% 10
2014
Q3
$7.28M Buy
55,484
+8,284
+18% +$987K 4.58% 9
2014
Q2
$5.95M Buy
47,200
+24,700
+110% +$3.15M 3.97% 11
2014
Q1
$2.97M Hold
22,500
2.44% 16
2013
Q4
$2.64M Hold
22,500
1.99% 18
2013
Q3
$2.35M Buy
+22,500
New +$2.19M 1.85% 19

Other funds holding BHC

Selkirk Management's BHC Position: Q1 2017 in Review

Selkirk Management sold out of Bausch Health (BHC) in Q1 2017, closing a stake of 102,000 shares — an estimated $1.48M sold.

Selkirk Management first reported a position in BHC in Q3 2013 and held it in 14 quarters. The position peaked at $12.3M in Q2 2015. 327 funds tracked by Wall St. Rank hold BHC as of Q1 2017.

  • Selkirk Management reported no remaining Bausch Health position as of Q1 2017 after selling out during the quarter.
  • Selkirk Management sold 102,000 Bausch Health shares in Q1 2017, an estimated $1.48M.
  • Selkirk Management first reported a position in Bausch Health in Q3 2013 and held it in 14 quarters.
  • Selkirk Management's Bausch Health position peaked at $12.3M in Q2 2015.
  • 327 funds tracked by Wall St. Rank held Bausch Health as of Q1 2017.

Based on Selkirk Management's 13F filing for Q1 2017, filed 15 May 2017.